Publicaties - Interne-geneeskunde

01dec

Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.

»

01nov

Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients.

»

01nov

Causes of death among patients diagnosed with chronic lymphocytic leukemia: A population-based study in the Netherlands, 1996-2020.

»

01nov

Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma.

»

01okt

First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.

»